- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 21.05. | Nanologica AB: Bulletin from the Annual General Meeting 2026 Nanologica AB (publ) | 430 | GlobeNewswire (Europe) | Nanologica AB (publ) today May 21, 2026 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted.
Adoption of the income statement and balance sheet, disposition... ► Artikel lesen | |
| 20.05. | Nanologica AB: Interim Report Q1 2026 Nanologica AB (publ) | 582 | GlobeNewswire (Europe) | FINANCIAL SUMMARYNet sales for the first quarter amounted to SEK 21,456 thousand (10,751).Operating profit for the quarter amounted to SEK 66,484 thousand (-9,241). Operating profit is affected by the... ► Artikel lesen | |
| 27.04. | Nanologica AB: Syntagon AB Recruits Alexandra Pichard Nielsen as Vice President Business Development | 814 | GlobeNewswire (Europe) | Syntagon AB, a subsidiary of Nanologica AB (publ), has recruited Alexandra Pichard Nielsen to the newly established role of Vice President Business Development. The recruitment is part of the strategy... ► Artikel lesen | |
| 26.03. | Nanologica AB: Nanologica Announces Outcome of Rights Issue | 893 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 06.03. | Nanologica AB: Nanologica Publishes Information Document Regarding Directed Share Issues and Rights Issue | 734 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 05.03. | XFRA CAPITAL ADJUSTMENT INFORMATION - 05.03.2026 | 497 | Xetra Newsboard | Das Instrument 4YD SE0005454873 NANOLOGICA AB EQUITY wird cum Kapitalmassnahme gehandelt am 05.03.2026 und ex Kapitalmassnahme am 06.03.2026 The instrument 4YD SE0005454873 NANOLOGICA AB EQUITY is traded... ► Artikel lesen | |
| 04.03. | Nanologica AB: Bulletin From The Extraordinary General Meeting In Nanologica AB (publ) | 450 | GlobeNewswire (Europe) | Nanologica AB (publ) ("Nanologica" or the "Company") held an extraordinary general meeting today at which the following resolutions were passed.
For more detailed information on the content of the resolutions... ► Artikel lesen | |
| 26.02. | Nanologica AB: Year-End Report 2025 Nanologica AB (publ) | 579 | GlobeNewswire (Europe) | FINANCIAL SUMMARYNet sales for the fourth quarter amounted to SEK 5,205 thousand (6,715) and for the full year to SEK 21,127 thousand (14,538)Operating loss for the quarter amounted to SEK -15,706 thousand... ► Artikel lesen | |
| NANOLOGICA Aktie jetzt für 0€ handeln | |||||
| 02.02. | Flerie AB: Flerie's portfolio company Nanologica acquires Syntagon | 606 | GlobeNewswire (Europe) | Flerie AB (publ)'s portfolio company Nanologica has acquired Ardena Södertälje AB ('Syntagon'), a contract manufacturer with 45 employees. The acquisition strengthens Nanologica's production capacity... ► Artikel lesen | |
| 30.01. | Nanologica AB: Nanologica Carries Out Directed Share Issues Of Approx. Sek 13.7 Million In Total, And A Fully Secured Rights Issue Of Approx. Sek 82.5 Million | 839 | GlobeNewswire (Europe) | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| 29.01. | Ardena Holding NV.: Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica | 809 | GlobeNewswire (Europe) | Ghent, Belgium, 29th January 2026 - Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of... ► Artikel lesen | |
| 23.10.25 | Nanologica AB: Interim Report Q3 2025 Nanologica AB (publ) | 744 | GlobeNewswire (Europe) | FINANCIAL SUMMARY Net sales for the third quarter amounted to SEK 2,843 thousand (611) and for the nine-month period to SEK 15,930 thousand (7,822)Operating loss for the quarter amounted to SEK -10... ► Artikel lesen | |
| 22.10.25 | Nanologica AB: Nanologica AB (publ) Receives Order of appx. SEK 1 Million In China | 541 | GlobeNewswire (Europe) | Nanologica has received an order for the company's silica-based purification media NLAB Saga® from a new distribution partner in China. The order relates to sampling NLAB Saga® to pharmaceutical manufacturers.
"This... ► Artikel lesen | |
| 01.10.25 | Nanologica AB: Nanologica AB (publ) Enters the Insulin Market in China | 469 | GlobeNewswire (Europe) | Nanologica has entered the insulin market in China with an order of approximately SEK 2 million for the company's silica-based purification media NLAB Saga®. The customer is an insulin manufacturer... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 18,600 | +1,09 % | Formycon steigert Umsatz deutlich und bestätigt Jahresprognose | Formycon hat im ersten Halbjahr 2026 den Umsatz nahezu verdreifacht und das operative Ergebnis deutlich verbessert. Der Biosimilar-Entwickler bestätigt seine Jahresprognose und meldet wichtige Fortschritte... ► Artikel lesen | |
| ONTO INNOVATION | 272,10 | -0,07 % | This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday | ||
| VEECO INSTRUMENTS | 46,040 | +4,61 % | VEECO INSTRUMENTS INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| RIBER | 9,460 | 0,00 % | RIBER: FIRST-HALF 2026 BUSINESS ACTIVITY Business growth, resilient order book and continued rollout of ROSIE | FIRST-HALF 2026 BUSINESS ACTIVITYBusiness growth, resilient order book and continued rollout of ROSIE Bezons, July 22, 2026 - 8:00 am - RIBER, the global leader in molecular beam epitaxy (MBE) equipment... ► Artikel lesen | |
| NVE | 100,00 | +0,50 % | Dividendenbekanntmachungen (03.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,026 EUR BF SPA IT0005187460 - 0,038 EUR CITIZENS & NORTHERN CORPORATION US1729221069 0... ► Artikel lesen | |
| GAUZY | 0,370 | +0,22 % | Gauzy Ltd. - 6-K, Report of foreign issuer | ||
| KOPIN | 4,460 | +2,13 % | Fabric.AI and Kopin Launch Joint Steering Committee Led by Kopin CEO Michael Murray as Neural I/o Industry Engagement Expands | ||
| NANOVEU | 0,050 | -1,98 % | XFRA Q2L: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| GOMSPACE | 1,066 | +1,72 % | GomSpace A/S: GomSpace Signs 24.4 MSEK Contract with Unseenlabs | Unseenlabs extends its existing cube satellites constellation.STOCKHOLM, July 1, 2026 /PRNewswire/ -- Today, GomSpace has signed an additional contract with Unseenlabs to deliver two new... ► Artikel lesen | |
| SOLESENCE | 0,860 | -2,91 % | Solésence, Inc.: Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results | Full Year 2025 record revenue of $62.1 million ROMEOVILLE, Ill., March 31, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty... ► Artikel lesen | |
| ACACIA RESEARCH | 3,940 | +2,07 % | ACACIA RESEARCH CORP - 10-Q, Quarterly Report | ||
| ADVANCE ZINCTEK | 0,366 | 0,00 % | ADVANCE ZINCTEK LIMITED: Change of Director's Interest Notice - Lev Mizikovsky | ||
| LAMPETIA | 0,161 | 0,00 % | EQS-Adhoc: Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten | EQS-Ad-hoc: Lampetia AG / Schlagwort(e): Sonstiges
Lampetia AG: Einigung über die Beendigung von Rechtsstreitigkeiten
16.07.2026 / 22:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
| NANOVIRICIDES | 1,140 | 0,00 % | NanoViricides: The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon | SHELTON, CT / ACCESS Newswire / August 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, announces that... ► Artikel lesen | |
| ZENTEK | 0,482 | 0,00 % | Zentek Ltd.: Zentek Files Provisional Patent Application for Absorption-Based EMI Shielding Coating Made from Albany Graphite | Guelph, Ontario--(Newsfile Corp. - August 17, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") has filed a provisional patent application with the United States Patent... ► Artikel lesen |
Das Unternehmen NANOLOGICA AB kann der Branche Nanotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +37,50 % bei einem Aktienkurs von 0,031 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NANOLOGICA AB finden Sie auf Wallstreet Online.